Temozolomide capsule Clinical Trials
4 recruitingDrug
Phase 24Phase 11
Showing 1–4 of 4 trials
Recruiting
Phase 2
The Efficacy and Safety of Temozolomide in SDH-deficient GIST
Gastrointestinal Stromal Tumors
Asan Medical Center29 enrolled1 locationNCT05661643
Recruiting
Phase 1Phase 2
5G-PEARL: Paxalisib in Malignant Brain Tumours
Glioblastoma Multiforme (GBM)Malignant Primary Gliomas
Institute of Cancer Research, United Kingdom64 enrolled1 locationNCT07391215
Recruiting
Phase 2
Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion
Solid TumorPrecision Medicine
Tianjin Medical University Second Hospital300 enrolled1 locationNCT06739395
Recruiting
Phase 2
Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study
Chemotherapy EffectNeuroendocrine TumorsFrailty
European Institute of Oncology46 enrolled1 locationNCT05554003